A new drug could help treat the debilitating symptoms of early stage Multiple Sclerosis according to latest research released on Thursday.
A study led by scientists from the University of Cambridge in the UK found that the drug Alemtuzumab can stop the progression of disability in MS sufferers in the early stages of the condition.
To comment, the following rules must be followed:
If you believe a comment violates the above rules, please use the Flagging Tool to alert a Moderator.
Flagging does not guarantee removal.
Decisions to suspend or unsuspend accounts are made by Station Moderators.
Questions may be sent to firstname.lastname@example.org. Please provide detailed information.